Regulus Therapeutics
RGLS
#8774
Rank
$0.11 B
Marketcap
$1.78
Share price
-1.39%
Change (1 day)
-31.99%
Change (1 year)

Regulus Therapeutics (RGLS) - Cash on Hand

Cash on Hand as of December 2024 : $75.77 Million USD

According to Regulus Therapeutics's latest financial reports the company has $75.77 Million USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Regulus Therapeutics - Cash on Hand chart (from 2011 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31$75.77 M218.83%
2023-12-31$23.76 M-39.31%
2022-12-31$39.16 M-35.15%
2021-12-31$60.38 M94.24%
2020-12-31$31.08 M-8.89%
2019-12-31$34.12 M144.86%
2018-12-31$13.93 M-76.8%
2017-12-31$60.07 M-21.07%
2016-12-31$76.11 M-33.27%
2015-12-31$0.11 B-28.6%
2014-12-31$0.15 B40.12%
2013-12-31$0.11 B16.21%
2012-12-31$98.1 M157.18%
2011-12-31$38.14 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$4.66 B 6,050.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
$8.24 B 10,785.84%๐Ÿ‡ซ๐Ÿ‡ท France
$2.37 B 3,034.20%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.65 B 7,361.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
$2.69 B 3,455.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$41.91 M-44.68%๐Ÿ‡บ๐Ÿ‡ธ USA
$10.85 B 14,230.21%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA